Loading insider details...
Latest Form 4 (Nov 16, 2026): Sale of 5,513 DYN shares, $92.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 16, 2026 | Dyne Therapeutics, Inc. (DYN) | Sale | 5,513 | $92.7K |
| Sep 8, 2026 | Dyne Therapeutics, Inc. (DYN) | Sale | 5,658 | $106.8K |
| Aug 17, 2026 | Dyne Therapeutics, Inc. (DYN) | Sale | 4,986 | $131.0K |
| Jun 17, 2026 | Dyne Therapeutics, Inc. (DYN) | Sale | 2,683 | $49.2K |
| May 14, 2026 | Dyne Therapeutics, Inc. (DYN) | Sale | 3,311 | $60.8K |
| Mar 6, 2026 | Dyne Therapeutics, Inc. (DYN) | Sale | 2,732 | $40.7K |
| Feb 17, 2026 | Dyne Therapeutics, Inc. (DYN) | Grant/Award | 180,000 | n/a |
| Dec 5, 2025 | Dyne Therapeutics, Inc. (DYN) | Sale | 2,662 | $55.2K |
| Sep 9, 2025 | Dyne Therapeutics, Inc. (DYN) | Sale | 2,640 | $35.4K |
| Jul 18, 2025 | Dyne Therapeutics, Inc. (DYN) | Grant/Award | 197,285 | n/a |